Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
NCT04976465Phase 1Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Jan 2018
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of aspirin and enoxaparin in systemic lupus erythematosus (SLE) (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoint: Live birth rate. Started Jan 2018; status: recruiting.
02
Drugs
aspirinenoxaparin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04976465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976465.